Article
Weight of ABCB1 and POR genes on oral tacrolimus exposure in CYP3A5 nonexpressor pediatric patients with stable kidney transplant.
The pharmacogenomics journal - 1 Jan 2018
Almeida-Paulo G N, Dapía García I, Lubomirov R, Borobia A M, Alonso-Sánchez N L, Espinosa L, Carcas-Sansuán A J
Abstract excerpt
Tacrolimus (TAC) is highly effective for the prevention of acute organ rejection. However, its clinical use may be challenging due to its large interindividual pharmacokinetic variability, which can be partially explained by genetic variations in TAC-metabolizing enzymes and transporters. The aim of this study was to evaluate the influence of genetic and clinical factors on TAC pharmacokinetic variability in 21...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
